Dolby Laboratories
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $304,806 | $288,818 | $364,523 | $315,574 |
Gross Profit | 270,810 | 253,155 | 325,746 | 283,514 |
EBITDA | 59,734 | 62,068 | 127,250 | 93,272 |
EBIT | 45,064 | 40,861 | 106,473 | 72,312 |
Net Income | 58,570 | 38,444 | 97,830 | 66,981 |
Net Change In Cash | 304,806 | 288,818 | 364,523 | 315,574 |
Free Cash Flow | 108,791 | 13,651 | 172,493 | 2,310 |
Cash | 577,752 | 741,636 | 709,535 | 656,816 |
Basic Shares | 96,593 | 96,959 | 96,856 | 97,439 |
Annual Financials
| Values in thousands | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|
Revenue | $1,273,721 | $1,009,182 | $1,253,793 | $1,281,256 |
Gross Profit | 1,133,225 | 892,168 | 1,112,433 | 1,151,231 |
EBITDA | 258,326 | 219,247 | 329,905 | 464,117 |
EBIT | 170,999 | 219,247 | 206,605 | 344,390 |
Net Income | 360,642 | 191,470 | 184,087 | 310,227 |
Net Change In Cash | 1,273,721 | 1,009,182 | 1,253,793 | 1,281,256 |
Cost of Revenue | -587,917 | 153,053 | ||
Free Cash Flow | 297,245 | 259,912 | 259,120 | 393,299 |
Cash | 482,047 | 745,364 | 620,127 | 1,225,380 |
Basic Shares | 97,325 | 97,588 | 101,983 | 104,622 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $1.14 |
2024-09-30 | $0.81 |
2024-06-30 | $0.71 |
2024-03-31 | $1.27 |
